Published articles

Published articles 1 records found  Search took 0.01 seconds. 
1.
10 p, 683.9 KB Ozanimod in relapsing multiple sclerosis : Pooled safety results from the clinical development program / Selmaj, Krzysztof W. (University of Warmia and Mazury) ; Cohen, Jeffrey A. (Neurological Institute) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Steinman, Lawrence (Stanford University Medical Center) ; Hartung, Hans-Peter (Medical University Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Cree, Bruce A. C (UCSF University of California San Francisco) ; Minton, Neil (Bristol Myers Squibb) ; Sheffield, James K. (Bristol Myers Squibb) ; Ding, Ning (Bristol Myers Squibb) ; Kappos, Ludwig (University of Basel) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for the treatment of relapsing multiple sclerosis (RMS). In phase 3 trials, ozanimod was well tolerated and superior to interferon beta-1a 30 µg once-weekly in reducing clinical and radiologic disease activity. [...]
2021 - 10.1016/j.msard.2021.102844
Multiple Sclerosis and Related Disorders, Vol. 51 (june 2021) , p. 102844  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.